Option chain shows key data for NanoVibronix's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for NanoVibronix.

NanoVibronix (NASDAQ:NAOV) Stock, Option Chain

NanoVibronix

NanoVibronix Inc manufactures noninvasive biological response-activating devices that target biofilm prevention, pain therapy, and wound healing and can be administered at home, without the assistance of medical professionals. Its primary products are UroShield; PainShield; and WoundShield. Each of its UroShield, PainShield, and WoundShield products employs a small, disposable transducer that transmits low-frequency, low-intensity ultrasound acoustic waves that seek to repair and regenerate tissue, musculoskeletal and vascular structures, and decrease biofilm formation on urinary catheters and associated urinary tract infections. The company derives revenues from selling its products directly to patients, through distributor agreements.

Stock Market Graph,Trading,Analysis,Investment,Financial,,Stock,Exchange,Financial

Exclusives

Trading Ideas

$SOL

AAPL

AMZN

AREB

BULL

CLSK

FMTO

ICCT

JNVR

MARA

NAOV

NMAX

NVDA

PLTR

RSLS

SMCI

TSLA

VERO

Each trading day features hundreds of headlines and press releases on Benzinga Pro, a source for traders to see the latest news on the overall market and individual tickers.

EXCLUSIVE: April&#39;s 20 Most-Searched Tickers On Benzinga Pro — Where Do Tesla, Apple, Palantir, Nvidia Stocks Rank?

Meta Platforms Inc. (META)

News

Pre-Market Outlook

Markets

ANET

BTMD

CFLT

COYA

ETWO

LGMK

MSFT

PAPL

PBPB

QCOM

RSVR

SGHC

SNDR

TRNR

VSTS

ZYBT

Why Meta Shares Are Trading Higher By Around 6%; Here Are 20 Stocks Moving Premarket

Driving Down Costs

Earnings

Equities

Eurozone

Commodities

Intraday Update

BJDX

CVRX

CYCU

SXTP

Dow Jumps Over 1,100 Points; US Small Business Sentiment Falls In March

NanoVibronix Inc

Press Releases

NanoVibronix Secures $12 Million Minimum Purchase Commitment for PainShield with Extension of Distribution Agreement

NanoVibronix Announces Completion of Pilot Phase of Clinical Study of UroShield® at the University of Michigan

NanoVibronix Advances Development of PainShield and UroShield with Completion of NextGen Prototypes

NanoVibronix, Inc. Announces Acquisition of ENvue Medical Holdings, Corp.

NanoVibronix Announces Reverse Stock Split

Successful Independent Study of the NanoVibronix UroShield® Device Published in the Australian and New Zealand Continence Journal

Power Metallic (TSXV: PNPN) Uses AI to Revolutionize Mining – Big Discoveries & More Tech Stocks Inside!

NanoVibronix Announces Renewal and Expansion of Distribution Agreement with Dukehill Healthcare Pty Ltd in Australia

NanoVibronix Regains Nasdaq Compliance

NanoVibronix Announces Results from UroShield™ Case Series

ACON

PNPNF

PRSO

TSXV:PNPN

Aethlon Medical

Autonomix Medical

Accelerate Diagnostics, Inc. - Common Stock

Accelerate Diagnostics

Bluejay Diagnostics

Biomerica

DIH Holding US, Inc. - Class A Common Stock

DIH Holding US

GlucoTrack

HeartSciences

Helius Medical Technologies, Inc. - Class A Common Stock

Helius Medical Tech

Intelligent Bio Solutions Inc. - Common Stock

Intelligent Bio Solutions

Know Labs

LogicMark

ENDRA Life Sciences

Nuwellis

Predictive Oncology

ReShape Lifesciences, Inc. - Common Stock

Reshape Lifesciences

SINTX Technologies

Tivic Health Systems, Inc. - Common stock

Tivic Health Systems

Tenon Medical

Venus Concept

Catheter Precision

Comments

NanoVibronix

NanoVibronix (NAOV) Options

No option chain data available. Please try again later

Connect With Us

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell